Product Benefits

• Dual-Action Therapy: Combines an alpha-blocker (Tamsulosin) for immediate symptom relief and a 5-alpha reductase inhibitor (Dutasteride) for long-term prostate shrinkage.

• Improved Urinary Flow: Significantly enhances the rate of urine flow by relaxing the smooth muscles in the bladder neck and prostate gland.

• Reduces Prostate Size: Dutasteride targets the root cause of BPH by inhibiting DHT production, leading to a physical reduction in the size of the enlarged prostate.

• Symptom Relief: Effectively minimizes bothersome symptoms such as frequent nighttime urination (nocturia), weak stream, hesitancy, and the feeling of incomplete bladder emptying.

• Prevents Complications: Clinical use significantly reduces the risk of sudden, painful inability to urinate (acute urinary retention).

• Avoids Surgery: Long-term management with Urolosin D can help many patients avoid the need for prostate-related surgical procedures (like TURP).

• Quality of Life: By restoring normal urinary function, it helps patients return to a more active lifestyle without the constant worry of bathroom proximity.

• Sustained Release Formula: The Tamsulosin component is often formulated for sustained release to provide consistent 24-hour relief with a single daily dose